nodes	percent_of_prediction	percent_of_DWPC	metapath
Desipramine—CYP2C18—Ifosfamide—testicular cancer	0.166	0.222	CbGbCtD
Desipramine—SLC22A5—Dactinomycin—testicular cancer	0.09	0.12	CbGbCtD
Desipramine—CYP2A6—Ifosfamide—testicular cancer	0.0808	0.108	CbGbCtD
Desipramine—SLC22A2—Vinblastine—testicular cancer	0.0538	0.0718	CbGbCtD
Desipramine—CYP2B6—Ifosfamide—testicular cancer	0.0526	0.0702	CbGbCtD
Desipramine—SLC22A2—Cisplatin—testicular cancer	0.0493	0.0658	CbGbCtD
Desipramine—CYP2C19—Ifosfamide—testicular cancer	0.0334	0.0446	CbGbCtD
Desipramine—CYP2B6—Cisplatin—testicular cancer	0.0256	0.0342	CbGbCtD
Desipramine—CYP2E1—Etoposide—testicular cancer	0.0255	0.034	CbGbCtD
Desipramine—ABCB1—Dactinomycin—testicular cancer	0.0229	0.0305	CbGbCtD
Desipramine—CYP2B6—Doxorubicin—testicular cancer	0.0172	0.0229	CbGbCtD
Desipramine—CYP3A4—Ifosfamide—testicular cancer	0.0162	0.0216	CbGbCtD
Desipramine—SMPD1—Ovarian Infertility Genes—DAZL—testicular cancer	0.0151	0.309	CbGpPWpGaD
Desipramine—CYP1A2—Etoposide—testicular cancer	0.0147	0.0197	CbGbCtD
Desipramine—ABCB1—Vinblastine—testicular cancer	0.0143	0.0191	CbGbCtD
Desipramine—CYP2D6—Vinblastine—testicular cancer	0.0135	0.018	CbGbCtD
Desipramine—ABCB1—Cisplatin—testicular cancer	0.0131	0.0175	CbGbCtD
Desipramine—ABCB1—Etoposide—testicular cancer	0.0129	0.0172	CbGbCtD
Desipramine—ABCB1—Doxorubicin—testicular cancer	0.0088	0.0117	CbGbCtD
Desipramine—CYP3A4—Vinblastine—testicular cancer	0.00858	0.0114	CbGbCtD
Desipramine—ABCB1—Methotrexate—testicular cancer	0.00852	0.0114	CbGbCtD
Desipramine—CYP2D6—Doxorubicin—testicular cancer	0.00829	0.0111	CbGbCtD
Desipramine—CYP3A4—Etoposide—testicular cancer	0.00773	0.0103	CbGbCtD
Desipramine—CYP3A4—Doxorubicin—testicular cancer	0.00527	0.00703	CbGbCtD
Desipramine—HTR2A—vein—testicular cancer	0.0027	0.106	CbGeAlD
Desipramine—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00188	0.0384	CbGpPWpGaD
Desipramine—SMPD1—gonad—testicular cancer	0.00157	0.0614	CbGeAlD
Desipramine—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00142	0.029	CbGpPWpGaD
Desipramine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00141	0.0289	CbGpPWpGaD
Desipramine—SMPD1—female gonad—testicular cancer	0.00128	0.0499	CbGeAlD
Desipramine—CYP2A6—seminal vesicle—testicular cancer	0.00117	0.0457	CbGeAlD
Desipramine—SMPD1—testis—testicular cancer	0.00113	0.0443	CbGeAlD
Desipramine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.0011	0.0225	CbGpPWpGaD
Desipramine—SLC22A4—seminal vesicle—testicular cancer	0.00102	0.0401	CbGeAlD
Desipramine—SLC22A3—embryo—testicular cancer	0.000993	0.0388	CbGeAlD
Desipramine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000978	0.02	CbGpPWpGaD
Desipramine—CHRM4—testis—testicular cancer	0.000964	0.0377	CbGeAlD
Desipramine—SLC22A3—seminal vesicle—testicular cancer	0.000933	0.0365	CbGeAlD
Desipramine—SLC6A4—NRF2 pathway—SLC2A6—testicular cancer	0.000925	0.0189	CbGpPWpGaD
Desipramine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00089	0.0182	CbGpPWpGaD
Desipramine—SLC22A4—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000855	0.0175	CbGpPWpGaD
Desipramine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000829	0.0169	CbGpPWpGaD
Desipramine—SMPD1—lymph node—testicular cancer	0.000821	0.0321	CbGeAlD
Desipramine—SLC6A2—NRF2 pathway—SLC2A6—testicular cancer	0.000796	0.0163	CbGpPWpGaD
Desipramine—SLC6A3—NRF2 pathway—SLC2A6—testicular cancer	0.000705	0.0144	CbGpPWpGaD
Desipramine—SLC22A5—seminal vesicle—testicular cancer	0.000678	0.0265	CbGeAlD
Desipramine—SLC22A3—gonad—testicular cancer	0.000674	0.0263	CbGeAlD
Desipramine—SLC22A3—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000644	0.0132	CbGpPWpGaD
Desipramine—SLC22A5—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000642	0.0131	CbGpPWpGaD
Desipramine—ADRB1—G alpha (s) signalling events—INSL3—testicular cancer	0.000636	0.013	CbGpPWpGaD
Desipramine—ADRB2—G alpha (s) signalling events—INSL3—testicular cancer	0.000623	0.0127	CbGpPWpGaD
Desipramine—CYP2A6—NRF2 pathway—SLC2A6—testicular cancer	0.000589	0.012	CbGpPWpGaD
Desipramine—SLC6A2—gonad—testicular cancer	0.000578	0.0226	CbGeAlD
Desipramine—CYP2E1—seminal vesicle—testicular cancer	0.000553	0.0216	CbGeAlD
Desipramine—SLC22A3—female gonad—testicular cancer	0.000548	0.0214	CbGeAlD
Desipramine—SLC6A3—testis—testicular cancer	0.000516	0.0202	CbGeAlD
Desipramine—HTR2A—embryo—testicular cancer	0.000511	0.02	CbGeAlD
Desipramine—SLC6A2—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000501	0.0102	CbGpPWpGaD
Desipramine—SLC22A3—testis—testicular cancer	0.000486	0.019	CbGeAlD
Desipramine—CHRM3—female gonad—testicular cancer	0.000475	0.0186	CbGeAlD
Desipramine—SLC6A3—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000444	0.00907	CbGpPWpGaD
Desipramine—SLC22A4—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000434	0.00887	CbGpPWpGaD
Desipramine—CYP2B6—gonad—testicular cancer	0.000426	0.0166	CbGeAlD
Desipramine—CHRM3—testis—testicular cancer	0.000421	0.0165	CbGeAlD
Desipramine—SLC6A2—testis—testicular cancer	0.000416	0.0163	CbGeAlD
Desipramine—SLC22A2—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000404	0.00826	CbGpPWpGaD
Desipramine—ORM1—lymph node—testicular cancer	0.000402	0.0157	CbGeAlD
Desipramine—SLC22A5—female gonad—testicular cancer	0.000398	0.0156	CbGeAlD
Desipramine—Tremor—Cisplatin—testicular cancer	0.000389	0.00221	CcSEcCtD
Desipramine—SLC22A4—lymph node—testicular cancer	0.000387	0.0151	CbGeAlD
Desipramine—Alopecia—Etoposide—testicular cancer	0.000386	0.00219	CcSEcCtD
Desipramine—Cerebrovascular accident—Methotrexate—testicular cancer	0.000386	0.00219	CcSEcCtD
Desipramine—Ill-defined disorder—Cisplatin—testicular cancer	0.000385	0.00219	CcSEcCtD
Desipramine—Thrombocytopenia—Ifosfamide—testicular cancer	0.000384	0.00218	CcSEcCtD
Desipramine—DRD2—testis—testicular cancer	0.000379	0.0148	CbGeAlD
Desipramine—Feeling abnormal—Bleomycin—testicular cancer	0.000379	0.00215	CcSEcCtD
Desipramine—Vomiting—Chlorambucil—testicular cancer	0.000377	0.00214	CcSEcCtD
Desipramine—SLC22A1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000377	0.0077	CbGpPWpGaD
Desipramine—Blood alkaline phosphatase increased—Doxorubicin—testicular cancer	0.000376	0.00214	CcSEcCtD
Desipramine—Anorexia—Ifosfamide—testicular cancer	0.000374	0.00213	CcSEcCtD
Desipramine—Malaise—Cisplatin—testicular cancer	0.000374	0.00212	CcSEcCtD
Desipramine—Decreased appetite—Dactinomycin—testicular cancer	0.000372	0.00212	CcSEcCtD
Desipramine—Diarrhoea—Vinblastine—testicular cancer	0.000372	0.00211	CcSEcCtD
Desipramine—Dysgeusia—Etoposide—testicular cancer	0.000372	0.00211	CcSEcCtD
Desipramine—CHRM4—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.00037	0.00755	CbGpPWpGaD
Desipramine—Fatigue—Dactinomycin—testicular cancer	0.000369	0.0021	CcSEcCtD
Desipramine—Purpura—Epirubicin—testicular cancer	0.000367	0.00208	CcSEcCtD
Desipramine—Hypotension—Ifosfamide—testicular cancer	0.000367	0.00208	CcSEcCtD
Desipramine—Vascular purpura—Doxorubicin—testicular cancer	0.000366	0.00208	CcSEcCtD
Desipramine—Urticaria—Bleomycin—testicular cancer	0.000365	0.00207	CcSEcCtD
Desipramine—Body temperature increased—Bleomycin—testicular cancer	0.000363	0.00206	CcSEcCtD
Desipramine—Cerebrovascular accident—Epirubicin—testicular cancer	0.000361	0.00205	CcSEcCtD
Desipramine—Dizziness—Vinblastine—testicular cancer	0.00036	0.00204	CcSEcCtD
Desipramine—Convulsion—Cisplatin—testicular cancer	0.000359	0.00204	CcSEcCtD
Desipramine—Ataxia—Methotrexate—testicular cancer	0.000355	0.00202	CcSEcCtD
Desipramine—CHRM5—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.000354	0.00723	CbGpPWpGaD
Desipramine—SLC22A5—testis—testicular cancer	0.000353	0.0138	CbGeAlD
Desipramine—Feeling abnormal—Dactinomycin—testicular cancer	0.000353	0.00201	CcSEcCtD
Desipramine—Nausea—Chlorambucil—testicular cancer	0.000353	0.002	CcSEcCtD
Desipramine—Paraesthesia—Ifosfamide—testicular cancer	0.000352	0.002	CcSEcCtD
Desipramine—Ill-defined disorder—Etoposide—testicular cancer	0.000352	0.002	CcSEcCtD
Desipramine—SLC22A3—lymph node—testicular cancer	0.000352	0.0138	CbGeAlD
Desipramine—Anxiety—Cisplatin—testicular cancer	0.000352	0.002	CcSEcCtD
Desipramine—Somnolence—Ifosfamide—testicular cancer	0.000349	0.00198	CcSEcCtD
Desipramine—Liver function test abnormal—Methotrexate—testicular cancer	0.000349	0.00198	CcSEcCtD
Desipramine—Discomfort—Cisplatin—testicular cancer	0.000349	0.00198	CcSEcCtD
Desipramine—HTR2A—gonad—testicular cancer	0.000347	0.0136	CbGeAlD
Desipramine—Vomiting—Vinblastine—testicular cancer	0.000346	0.00196	CcSEcCtD
Desipramine—Malaise—Etoposide—testicular cancer	0.000343	0.00195	CcSEcCtD
Desipramine—Decreased appetite—Ifosfamide—testicular cancer	0.000341	0.00194	CcSEcCtD
Desipramine—Headache—Vinblastine—testicular cancer	0.000341	0.00194	CcSEcCtD
Desipramine—Purpura—Doxorubicin—testicular cancer	0.000339	0.00193	CcSEcCtD
Desipramine—Body temperature increased—Dactinomycin—testicular cancer	0.000339	0.00192	CcSEcCtD
Desipramine—Abdominal pain—Dactinomycin—testicular cancer	0.000339	0.00192	CcSEcCtD
Desipramine—Fatigue—Ifosfamide—testicular cancer	0.000338	0.00192	CcSEcCtD
Desipramine—Oedema—Cisplatin—testicular cancer	0.000338	0.00192	CcSEcCtD
Desipramine—HRH1—female gonad—testicular cancer	0.000338	0.0132	CbGeAlD
Desipramine—Constipation—Ifosfamide—testicular cancer	0.000336	0.00191	CcSEcCtD
Desipramine—ABCB1—embryo—testicular cancer	0.000335	0.0131	CbGeAlD
Desipramine—Cerebrovascular accident—Doxorubicin—testicular cancer	0.000334	0.0019	CcSEcCtD
Desipramine—Ataxia—Epirubicin—testicular cancer	0.000332	0.00189	CcSEcCtD
Desipramine—Thrombocytopenia—Cisplatin—testicular cancer	0.000331	0.00188	CcSEcCtD
Desipramine—Tachycardia—Cisplatin—testicular cancer	0.00033	0.00188	CcSEcCtD
Desipramine—Asthenia—Bleomycin—testicular cancer	0.00033	0.00187	CcSEcCtD
Desipramine—Convulsion—Etoposide—testicular cancer	0.000329	0.00187	CcSEcCtD
Desipramine—Hypertension—Etoposide—testicular cancer	0.000328	0.00186	CcSEcCtD
Desipramine—SLC22A3—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000327	0.00669	CbGpPWpGaD
Desipramine—Liver function test abnormal—Epirubicin—testicular cancer	0.000326	0.00185	CcSEcCtD
Desipramine—SLC22A5—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000326	0.00667	CbGpPWpGaD
Desipramine—Pruritus—Bleomycin—testicular cancer	0.000325	0.00185	CcSEcCtD
Desipramine—Feeling abnormal—Ifosfamide—testicular cancer	0.000323	0.00184	CcSEcCtD
Desipramine—Eosinophilia—Methotrexate—testicular cancer	0.000323	0.00184	CcSEcCtD
Desipramine—Nausea—Vinblastine—testicular cancer	0.000323	0.00183	CcSEcCtD
Desipramine—Anorexia—Cisplatin—testicular cancer	0.000323	0.00183	CcSEcCtD
Desipramine—Discomfort—Etoposide—testicular cancer	0.00032	0.00181	CcSEcCtD
Desipramine—Hypotension—Cisplatin—testicular cancer	0.000316	0.0018	CcSEcCtD
Desipramine—ABCB1—seminal vesicle—testicular cancer	0.000315	0.0123	CbGeAlD
Desipramine—Confusional state—Etoposide—testicular cancer	0.000313	0.00178	CcSEcCtD
Desipramine—Urticaria—Ifosfamide—testicular cancer	0.000312	0.00177	CcSEcCtD
Desipramine—Body temperature increased—Ifosfamide—testicular cancer	0.00031	0.00176	CcSEcCtD
Desipramine—Abdominal pain—Ifosfamide—testicular cancer	0.00031	0.00176	CcSEcCtD
Desipramine—Ataxia—Doxorubicin—testicular cancer	0.000308	0.00175	CcSEcCtD
Desipramine—CYP2C18—Biological oxidations—HPGDS—testicular cancer	0.000308	0.00628	CbGpPWpGaD
Desipramine—Asthenia—Dactinomycin—testicular cancer	0.000307	0.00175	CcSEcCtD
Desipramine—CYP2C19—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000307	0.00627	CbGpPWpGaD
Desipramine—CYP2B6—testis—testicular cancer	0.000307	0.012	CbGeAlD
Desipramine—Paraesthesia—Cisplatin—testicular cancer	0.000304	0.00173	CcSEcCtD
Desipramine—Thrombocytopenia—Etoposide—testicular cancer	0.000304	0.00172	CcSEcCtD
Desipramine—ADRB1—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.000303	0.0062	CbGpPWpGaD
Desipramine—Tachycardia—Etoposide—testicular cancer	0.000303	0.00172	CcSEcCtD
Desipramine—Eosinophilia—Epirubicin—testicular cancer	0.000303	0.00172	CcSEcCtD
Desipramine—Liver function test abnormal—Doxorubicin—testicular cancer	0.000302	0.00172	CcSEcCtD
Desipramine—SLC6A2—lymph node—testicular cancer	0.000302	0.0118	CbGeAlD
Desipramine—Erectile dysfunction—Methotrexate—testicular cancer	0.000301	0.00171	CcSEcCtD
Desipramine—HRH1—testis—testicular cancer	0.0003	0.0117	CbGeAlD
Desipramine—ADRB2—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.000297	0.00606	CbGpPWpGaD
Desipramine—Anorexia—Etoposide—testicular cancer	0.000296	0.00168	CcSEcCtD
Desipramine—Decreased appetite—Cisplatin—testicular cancer	0.000294	0.00167	CcSEcCtD
Desipramine—Diarrhoea—Dactinomycin—testicular cancer	0.000293	0.00166	CcSEcCtD
Desipramine—Vomiting—Bleomycin—testicular cancer	0.000292	0.00166	CcSEcCtD
Desipramine—Drowsiness—Methotrexate—testicular cancer	0.000291	0.00165	CcSEcCtD
Desipramine—Depression—Methotrexate—testicular cancer	0.00029	0.00165	CcSEcCtD
Desipramine—HTR1A—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.00029	0.00593	CbGpPWpGaD
Desipramine—Hypotension—Etoposide—testicular cancer	0.00029	0.00165	CcSEcCtD
Desipramine—Rash—Bleomycin—testicular cancer	0.00029	0.00164	CcSEcCtD
Desipramine—Dermatitis—Bleomycin—testicular cancer	0.000289	0.00164	CcSEcCtD
Desipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.000289	0.0059	CbGpPWpGaD
Desipramine—SMPD1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000289	0.0059	CbGpPWpGaD
Desipramine—CYP2E1—testis—testicular cancer	0.000288	0.0113	CbGeAlD
Desipramine—Stomatitis—Methotrexate—testicular cancer	0.000284	0.00161	CcSEcCtD
Desipramine—Pollakiuria—Epirubicin—testicular cancer	0.000282	0.0016	CcSEcCtD
Desipramine—CHRM4—GPCR ligand binding—INSL3—testicular cancer	0.000282	0.00575	CbGpPWpGaD
Desipramine—Asthenia—Ifosfamide—testicular cancer	0.000282	0.0016	CcSEcCtD
Desipramine—Eosinophilia—Doxorubicin—testicular cancer	0.00028	0.00159	CcSEcCtD
Desipramine—Feeling abnormal—Cisplatin—testicular cancer	0.000279	0.00158	CcSEcCtD
Desipramine—Paraesthesia—Etoposide—testicular cancer	0.000278	0.00158	CcSEcCtD
Desipramine—Weight increased—Epirubicin—testicular cancer	0.000278	0.00158	CcSEcCtD
Desipramine—Pruritus—Ifosfamide—testicular cancer	0.000278	0.00158	CcSEcCtD
Desipramine—Somnolence—Etoposide—testicular cancer	0.000276	0.00157	CcSEcCtD
Desipramine—Nausea—Bleomycin—testicular cancer	0.000273	0.00155	CcSEcCtD
Desipramine—Drowsiness—Epirubicin—testicular cancer	0.000272	0.00155	CcSEcCtD
Desipramine—Vomiting—Dactinomycin—testicular cancer	0.000272	0.00155	CcSEcCtD
Desipramine—Agranulocytosis—Methotrexate—testicular cancer	0.000272	0.00154	CcSEcCtD
Desipramine—Rash—Dactinomycin—testicular cancer	0.00027	0.00153	CcSEcCtD
Desipramine—CHRM5—GPCR ligand binding—INSL3—testicular cancer	0.00027	0.00551	CbGpPWpGaD
Desipramine—Decreased appetite—Etoposide—testicular cancer	0.00027	0.00153	CcSEcCtD
Desipramine—Diarrhoea—Ifosfamide—testicular cancer	0.000269	0.00153	CcSEcCtD
Desipramine—Body temperature increased—Cisplatin—testicular cancer	0.000268	0.00152	CcSEcCtD
Desipramine—Fatigue—Etoposide—testicular cancer	0.000267	0.00152	CcSEcCtD
Desipramine—Neuropathy peripheral—Epirubicin—testicular cancer	0.000267	0.00152	CcSEcCtD
Desipramine—Jaundice—Epirubicin—testicular cancer	0.000266	0.00151	CcSEcCtD
Desipramine—Stomatitis—Epirubicin—testicular cancer	0.000266	0.00151	CcSEcCtD
Desipramine—Constipation—Etoposide—testicular cancer	0.000265	0.00151	CcSEcCtD
Desipramine—Hepatitis—Methotrexate—testicular cancer	0.000261	0.00148	CcSEcCtD
Desipramine—Pollakiuria—Doxorubicin—testicular cancer	0.000261	0.00148	CcSEcCtD
Desipramine—Dizziness—Ifosfamide—testicular cancer	0.00026	0.00147	CcSEcCtD
Desipramine—Weight increased—Doxorubicin—testicular cancer	0.000257	0.00146	CcSEcCtD
Desipramine—CYP2D6—female gonad—testicular cancer	0.000257	0.01	CbGeAlD
Desipramine—SLC22A5—lymph node—testicular cancer	0.000256	0.01	CbGeAlD
Desipramine—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	0.000256	0.00522	CbGpPWpGaD
Desipramine—Feeling abnormal—Etoposide—testicular cancer	0.000255	0.00145	CcSEcCtD
Desipramine—SLC6A2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000255	0.00521	CbGpPWpGaD
Desipramine—DRD2—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.000255	0.00521	CbGpPWpGaD
Desipramine—Nausea—Dactinomycin—testicular cancer	0.000254	0.00145	CcSEcCtD
Desipramine—Agranulocytosis—Epirubicin—testicular cancer	0.000254	0.00144	CcSEcCtD
Desipramine—Drowsiness—Doxorubicin—testicular cancer	0.000252	0.00143	CcSEcCtD
Desipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.000251	0.00512	CbGpPWpGaD
Desipramine—HRH1—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.00025	0.00511	CbGpPWpGaD
Desipramine—HTR2A—testis—testicular cancer	0.00025	0.00978	CbGeAlD
Desipramine—Vomiting—Ifosfamide—testicular cancer	0.00025	0.00142	CcSEcCtD
Desipramine—CHRM1—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.000249	0.00509	CbGpPWpGaD
Desipramine—CHRM3—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.000249	0.00508	CbGpPWpGaD
Desipramine—Rash—Ifosfamide—testicular cancer	0.000248	0.00141	CcSEcCtD
Desipramine—Dermatitis—Ifosfamide—testicular cancer	0.000247	0.0014	CcSEcCtD
Desipramine—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000247	0.0014	CcSEcCtD
Desipramine—Urticaria—Etoposide—testicular cancer	0.000246	0.0014	CcSEcCtD
Desipramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.000246	0.00503	CbGpPWpGaD
Desipramine—Stomatitis—Doxorubicin—testicular cancer	0.000246	0.0014	CcSEcCtD
Desipramine—Jaundice—Doxorubicin—testicular cancer	0.000246	0.0014	CcSEcCtD
Desipramine—Body temperature increased—Etoposide—testicular cancer	0.000245	0.00139	CcSEcCtD
Desipramine—Abdominal pain—Etoposide—testicular cancer	0.000245	0.00139	CcSEcCtD
Desipramine—Hepatitis—Epirubicin—testicular cancer	0.000245	0.00139	CcSEcCtD
Desipramine—Tinnitus—Methotrexate—testicular cancer	0.000244	0.00138	CcSEcCtD
Desipramine—Hypoaesthesia—Epirubicin—testicular cancer	0.000243	0.00138	CcSEcCtD
Desipramine—Asthenia—Cisplatin—testicular cancer	0.000243	0.00138	CcSEcCtD
Desipramine—CYP1A2—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000239	0.00489	CbGpPWpGaD
Desipramine—Agranulocytosis—Doxorubicin—testicular cancer	0.000235	0.00134	CcSEcCtD
Desipramine—Nausea—Ifosfamide—testicular cancer	0.000233	0.00132	CcSEcCtD
Desipramine—Diarrhoea—Cisplatin—testicular cancer	0.000232	0.00132	CcSEcCtD
Desipramine—ADRB1—GPCR ligand binding—INSL3—testicular cancer	0.000231	0.00472	CbGpPWpGaD
Desipramine—Alopecia—Methotrexate—testicular cancer	0.000231	0.00131	CcSEcCtD
Desipramine—Tinnitus—Epirubicin—testicular cancer	0.000228	0.0013	CcSEcCtD
Desipramine—CYP2D6—testis—testicular cancer	0.000228	0.00891	CbGeAlD
Desipramine—ABCB1—gonad—testicular cancer	0.000227	0.00889	CbGeAlD
Desipramine—Flushing—Epirubicin—testicular cancer	0.000227	0.00129	CcSEcCtD
Desipramine—Hepatitis—Doxorubicin—testicular cancer	0.000226	0.00129	CcSEcCtD
Desipramine—ADRB2—GPCR ligand binding—INSL3—testicular cancer	0.000226	0.00462	CbGpPWpGaD
Desipramine—SLC6A3—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000226	0.00461	CbGpPWpGaD
Desipramine—Hypoaesthesia—Doxorubicin—testicular cancer	0.000225	0.00128	CcSEcCtD
Desipramine—Dysgeusia—Methotrexate—testicular cancer	0.000223	0.00127	CcSEcCtD
Desipramine—Asthenia—Etoposide—testicular cancer	0.000222	0.00126	CcSEcCtD
Desipramine—HTR1A—GPCR ligand binding—INSL3—testicular cancer	0.000221	0.00451	CbGpPWpGaD
Desipramine—HTR2C—GPCR ligand binding—INSL3—testicular cancer	0.00022	0.00449	CbGpPWpGaD
Desipramine—Pruritus—Etoposide—testicular cancer	0.000219	0.00125	CcSEcCtD
Desipramine—Arrhythmia—Epirubicin—testicular cancer	0.000219	0.00124	CcSEcCtD
Desipramine—HRH1—lymph node—testicular cancer	0.000217	0.00849	CbGeAlD
Desipramine—Alopecia—Epirubicin—testicular cancer	0.000216	0.00123	CcSEcCtD
Desipramine—Vomiting—Cisplatin—testicular cancer	0.000215	0.00122	CcSEcCtD
Desipramine—Vision blurred—Methotrexate—testicular cancer	0.000214	0.00122	CcSEcCtD
Desipramine—Rash—Cisplatin—testicular cancer	0.000213	0.00121	CcSEcCtD
Desipramine—Dermatitis—Cisplatin—testicular cancer	0.000213	0.00121	CcSEcCtD
Desipramine—Diarrhoea—Etoposide—testicular cancer	0.000212	0.0012	CcSEcCtD
Desipramine—Ill-defined disorder—Methotrexate—testicular cancer	0.000211	0.0012	CcSEcCtD
Desipramine—Tinnitus—Doxorubicin—testicular cancer	0.000211	0.0012	CcSEcCtD
Desipramine—Flushing—Doxorubicin—testicular cancer	0.00021	0.00119	CcSEcCtD
Desipramine—Dysgeusia—Epirubicin—testicular cancer	0.000209	0.00118	CcSEcCtD
Desipramine—SLC22A2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000205	0.0042	CbGpPWpGaD
Desipramine—Malaise—Methotrexate—testicular cancer	0.000205	0.00117	CcSEcCtD
Desipramine—Dizziness—Etoposide—testicular cancer	0.000205	0.00116	CcSEcCtD
Desipramine—Arrhythmia—Doxorubicin—testicular cancer	0.000202	0.00115	CcSEcCtD
Desipramine—Nausea—Cisplatin—testicular cancer	0.000201	0.00114	CcSEcCtD
Desipramine—Vision blurred—Epirubicin—testicular cancer	0.000201	0.00114	CcSEcCtD
Desipramine—Alopecia—Doxorubicin—testicular cancer	0.0002	0.00114	CcSEcCtD
Desipramine—Ill-defined disorder—Epirubicin—testicular cancer	0.000198	0.00112	CcSEcCtD
Desipramine—Convulsion—Methotrexate—testicular cancer	0.000197	0.00112	CcSEcCtD
Desipramine—Vomiting—Etoposide—testicular cancer	0.000197	0.00112	CcSEcCtD
Desipramine—Agitation—Epirubicin—testicular cancer	0.000196	0.00111	CcSEcCtD
Desipramine—Rash—Etoposide—testicular cancer	0.000195	0.00111	CcSEcCtD
Desipramine—Dermatitis—Etoposide—testicular cancer	0.000195	0.00111	CcSEcCtD
Desipramine—Headache—Etoposide—testicular cancer	0.000194	0.0011	CcSEcCtD
Desipramine—DRD2—GPCR ligand binding—INSL3—testicular cancer	0.000194	0.00396	CbGpPWpGaD
Desipramine—Dysgeusia—Doxorubicin—testicular cancer	0.000193	0.0011	CcSEcCtD
Desipramine—Malaise—Epirubicin—testicular cancer	0.000192	0.00109	CcSEcCtD
Desipramine—SLC22A1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000191	0.00391	CbGpPWpGaD
Desipramine—Discomfort—Methotrexate—testicular cancer	0.000191	0.00109	CcSEcCtD
Desipramine—CHRM3—Integration of energy metabolism—STK11—testicular cancer	0.000191	0.0039	CbGpPWpGaD
Desipramine—HTR2A—GPCR ligand binding—INSL3—testicular cancer	0.000191	0.0039	CbGpPWpGaD
Desipramine—HRH1—GPCR ligand binding—INSL3—testicular cancer	0.000191	0.00389	CbGpPWpGaD
Desipramine—CHRM1—GPCR ligand binding—INSL3—testicular cancer	0.00019	0.00388	CbGpPWpGaD
Desipramine—CHRM3—GPCR ligand binding—INSL3—testicular cancer	0.000189	0.00387	CbGpPWpGaD
Desipramine—Palpitations—Epirubicin—testicular cancer	0.000188	0.00107	CcSEcCtD
Desipramine—CHRM2—GPCR ligand binding—INSL3—testicular cancer	0.000187	0.00383	CbGpPWpGaD
Desipramine—CYP2A6—Biological oxidations—HPGDS—testicular cancer	0.000187	0.00383	CbGpPWpGaD
Desipramine—Confusional state—Methotrexate—testicular cancer	0.000187	0.00106	CcSEcCtD
Desipramine—Vision blurred—Doxorubicin—testicular cancer	0.000186	0.00105	CcSEcCtD
Desipramine—ABCB1—female gonad—testicular cancer	0.000185	0.00723	CbGeAlD
Desipramine—Convulsion—Epirubicin—testicular cancer	0.000185	0.00105	CcSEcCtD
Desipramine—Nausea—Etoposide—testicular cancer	0.000184	0.00105	CcSEcCtD
Desipramine—Hypertension—Epirubicin—testicular cancer	0.000184	0.00104	CcSEcCtD
Desipramine—Ill-defined disorder—Doxorubicin—testicular cancer	0.000183	0.00104	CcSEcCtD
Desipramine—Thrombocytopenia—Methotrexate—testicular cancer	0.000182	0.00103	CcSEcCtD
Desipramine—Agitation—Doxorubicin—testicular cancer	0.000181	0.00103	CcSEcCtD
Desipramine—Anxiety—Epirubicin—testicular cancer	0.000181	0.00103	CcSEcCtD
Desipramine—Discomfort—Epirubicin—testicular cancer	0.000179	0.00102	CcSEcCtD
Desipramine—Malaise—Doxorubicin—testicular cancer	0.000178	0.00101	CcSEcCtD
Desipramine—Dry mouth—Epirubicin—testicular cancer	0.000177	0.00101	CcSEcCtD
Desipramine—Anorexia—Methotrexate—testicular cancer	0.000177	0.00101	CcSEcCtD
Desipramine—Confusional state—Epirubicin—testicular cancer	0.000175	0.000995	CcSEcCtD
Desipramine—Palpitations—Doxorubicin—testicular cancer	0.000174	0.000989	CcSEcCtD
Desipramine—Oedema—Epirubicin—testicular cancer	0.000174	0.000987	CcSEcCtD
Desipramine—Hypotension—Methotrexate—testicular cancer	0.000174	0.000986	CcSEcCtD
Desipramine—Convulsion—Doxorubicin—testicular cancer	0.000171	0.00097	CcSEcCtD
Desipramine—Thrombocytopenia—Epirubicin—testicular cancer	0.00017	0.000966	CcSEcCtD
Desipramine—Hypertension—Doxorubicin—testicular cancer	0.00017	0.000966	CcSEcCtD
Desipramine—Tachycardia—Epirubicin—testicular cancer	0.00017	0.000963	CcSEcCtD
Desipramine—Insomnia—Methotrexate—testicular cancer	0.000168	0.000954	CcSEcCtD
Desipramine—Anxiety—Doxorubicin—testicular cancer	0.000167	0.000949	CcSEcCtD
Desipramine—Paraesthesia—Methotrexate—testicular cancer	0.000167	0.000947	CcSEcCtD
Desipramine—Discomfort—Doxorubicin—testicular cancer	0.000166	0.000941	CcSEcCtD
Desipramine—Anorexia—Epirubicin—testicular cancer	0.000166	0.000941	CcSEcCtD
Desipramine—Somnolence—Methotrexate—testicular cancer	0.000165	0.000938	CcSEcCtD
Desipramine—Dry mouth—Doxorubicin—testicular cancer	0.000164	0.000932	CcSEcCtD
Desipramine—ABCB1—testis—testicular cancer	0.000164	0.00641	CbGeAlD
Desipramine—Dyspepsia—Methotrexate—testicular cancer	0.000163	0.000928	CcSEcCtD
Desipramine—Hypotension—Epirubicin—testicular cancer	0.000162	0.000922	CcSEcCtD
Desipramine—Confusional state—Doxorubicin—testicular cancer	0.000162	0.000921	CcSEcCtD
Desipramine—Decreased appetite—Methotrexate—testicular cancer	0.000161	0.000917	CcSEcCtD
Desipramine—Oedema—Doxorubicin—testicular cancer	0.000161	0.000913	CcSEcCtD
Desipramine—Fatigue—Methotrexate—testicular cancer	0.00016	0.000909	CcSEcCtD
Desipramine—CHRM4—GPCR downstream signaling—INSL3—testicular cancer	0.000159	0.00325	CbGpPWpGaD
Desipramine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000157	0.000894	CcSEcCtD
Desipramine—Insomnia—Epirubicin—testicular cancer	0.000157	0.000893	CcSEcCtD
Desipramine—Tachycardia—Doxorubicin—testicular cancer	0.000157	0.000891	CcSEcCtD
Desipramine—Paraesthesia—Epirubicin—testicular cancer	0.000156	0.000886	CcSEcCtD
Desipramine—Somnolence—Epirubicin—testicular cancer	0.000155	0.000878	CcSEcCtD
Desipramine—Anorexia—Doxorubicin—testicular cancer	0.000153	0.000871	CcSEcCtD
Desipramine—Feeling abnormal—Methotrexate—testicular cancer	0.000153	0.000869	CcSEcCtD
Desipramine—Dyspepsia—Epirubicin—testicular cancer	0.000153	0.000869	CcSEcCtD
Desipramine—CHRM5—GPCR downstream signaling—INSL3—testicular cancer	0.000152	0.00311	CbGpPWpGaD
Desipramine—CYP1A2—Phase II conjugation—HPGDS—testicular cancer	0.000152	0.00311	CbGpPWpGaD
Desipramine—CYP2B6—Biological oxidations—HPGDS—testicular cancer	0.000151	0.00309	CbGpPWpGaD
Desipramine—Decreased appetite—Epirubicin—testicular cancer	0.000151	0.000858	CcSEcCtD
Desipramine—Hypotension—Doxorubicin—testicular cancer	0.00015	0.000853	CcSEcCtD
Desipramine—Fatigue—Epirubicin—testicular cancer	0.00015	0.000851	CcSEcCtD
Desipramine—Constipation—Epirubicin—testicular cancer	0.000149	0.000844	CcSEcCtD
Desipramine—CYP2E1—Biological oxidations—HPGDS—testicular cancer	0.000148	0.00303	CbGpPWpGaD
Desipramine—Urticaria—Methotrexate—testicular cancer	0.000148	0.000838	CcSEcCtD
Desipramine—Body temperature increased—Methotrexate—testicular cancer	0.000147	0.000834	CcSEcCtD
Desipramine—Abdominal pain—Methotrexate—testicular cancer	0.000147	0.000834	CcSEcCtD
Desipramine—CHRM4—Regulation of Actin Cytoskeleton—FGFR3—testicular cancer	0.000147	0.00299	CbGpPWpGaD
Desipramine—Insomnia—Doxorubicin—testicular cancer	0.000145	0.000826	CcSEcCtD
Desipramine—CHRM4—Signaling by GPCR—INSL3—testicular cancer	0.000145	0.00295	CbGpPWpGaD
Desipramine—Paraesthesia—Doxorubicin—testicular cancer	0.000144	0.00082	CcSEcCtD
Desipramine—Feeling abnormal—Epirubicin—testicular cancer	0.000143	0.000813	CcSEcCtD
Desipramine—Somnolence—Doxorubicin—testicular cancer	0.000143	0.000812	CcSEcCtD
Desipramine—Dyspepsia—Doxorubicin—testicular cancer	0.000142	0.000804	CcSEcCtD
Desipramine—CHRM5—Regulation of Actin Cytoskeleton—FGFR3—testicular cancer	0.00014	0.00287	CbGpPWpGaD
Desipramine—Decreased appetite—Doxorubicin—testicular cancer	0.00014	0.000794	CcSEcCtD
Desipramine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—testicular cancer	0.00014	0.00285	CbGpPWpGaD
Desipramine—Fatigue—Doxorubicin—testicular cancer	0.000139	0.000787	CcSEcCtD
Desipramine—CHRM5—Signaling by GPCR—INSL3—testicular cancer	0.000138	0.00283	CbGpPWpGaD
Desipramine—Urticaria—Epirubicin—testicular cancer	0.000138	0.000784	CcSEcCtD
Desipramine—Constipation—Doxorubicin—testicular cancer	0.000138	0.000781	CcSEcCtD
Desipramine—Body temperature increased—Epirubicin—testicular cancer	0.000137	0.00078	CcSEcCtD
Desipramine—Abdominal pain—Epirubicin—testicular cancer	0.000137	0.00078	CcSEcCtD
Desipramine—Asthenia—Methotrexate—testicular cancer	0.000133	0.000757	CcSEcCtD
Desipramine—Feeling abnormal—Doxorubicin—testicular cancer	0.000133	0.000753	CcSEcCtD
Desipramine—Pruritus—Methotrexate—testicular cancer	0.000131	0.000746	CcSEcCtD
Desipramine—ADRB1—GPCR downstream signaling—INSL3—testicular cancer	0.000131	0.00267	CbGpPWpGaD
Desipramine—SMPD1—Metabolism—HPGDS—testicular cancer	0.000129	0.00263	CbGpPWpGaD
Desipramine—Urticaria—Doxorubicin—testicular cancer	0.000128	0.000726	CcSEcCtD
Desipramine—ADRB2—GPCR downstream signaling—INSL3—testicular cancer	0.000128	0.00261	CbGpPWpGaD
Desipramine—Abdominal pain—Doxorubicin—testicular cancer	0.000127	0.000722	CcSEcCtD
Desipramine—Body temperature increased—Doxorubicin—testicular cancer	0.000127	0.000722	CcSEcCtD
Desipramine—Diarrhoea—Methotrexate—testicular cancer	0.000127	0.000722	CcSEcCtD
Desipramine—HTR1A—GPCR downstream signaling—INSL3—testicular cancer	0.000125	0.00255	CbGpPWpGaD
Desipramine—Asthenia—Epirubicin—testicular cancer	0.000125	0.000708	CcSEcCtD
Desipramine—HTR2C—GPCR downstream signaling—INSL3—testicular cancer	0.000124	0.00254	CbGpPWpGaD
Desipramine—Pruritus—Epirubicin—testicular cancer	0.000123	0.000698	CcSEcCtD
Desipramine—Dizziness—Methotrexate—testicular cancer	0.000123	0.000698	CcSEcCtD
Desipramine—Diarrhoea—Epirubicin—testicular cancer	0.000119	0.000675	CcSEcCtD
Desipramine—ABCB1—lymph node—testicular cancer	0.000119	0.00465	CbGeAlD
Desipramine—ADRB1—Signaling by GPCR—INSL3—testicular cancer	0.000119	0.00242	CbGpPWpGaD
Desipramine—Vomiting—Methotrexate—testicular cancer	0.000118	0.000671	CcSEcCtD
Desipramine—Rash—Methotrexate—testicular cancer	0.000117	0.000665	CcSEcCtD
Desipramine—Dermatitis—Methotrexate—testicular cancer	0.000117	0.000664	CcSEcCtD
Desipramine—Headache—Methotrexate—testicular cancer	0.000116	0.000661	CcSEcCtD
Desipramine—ADRB2—Signaling by GPCR—INSL3—testicular cancer	0.000116	0.00237	CbGpPWpGaD
Desipramine—Asthenia—Doxorubicin—testicular cancer	0.000115	0.000655	CcSEcCtD
Desipramine—Dizziness—Epirubicin—testicular cancer	0.000115	0.000653	CcSEcCtD
Desipramine—CYP2C19—Biological oxidations—HPGDS—testicular cancer	0.000114	0.00233	CbGpPWpGaD
Desipramine—Pruritus—Doxorubicin—testicular cancer	0.000114	0.000646	CcSEcCtD
Desipramine—HTR1A—Signaling by GPCR—INSL3—testicular cancer	0.000113	0.00232	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—INSL3—testicular cancer	0.000113	0.0023	CbGpPWpGaD
Desipramine—ABCB1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000112	0.00229	CbGpPWpGaD
Desipramine—Vomiting—Epirubicin—testicular cancer	0.000111	0.000628	CcSEcCtD
Desipramine—Nausea—Methotrexate—testicular cancer	0.00011	0.000627	CcSEcCtD
Desipramine—Diarrhoea—Doxorubicin—testicular cancer	0.00011	0.000625	CcSEcCtD
Desipramine—DRD2—GPCR downstream signaling—INSL3—testicular cancer	0.00011	0.00224	CbGpPWpGaD
Desipramine—Rash—Epirubicin—testicular cancer	0.00011	0.000622	CcSEcCtD
Desipramine—Dermatitis—Epirubicin—testicular cancer	0.000109	0.000622	CcSEcCtD
Desipramine—Headache—Epirubicin—testicular cancer	0.000109	0.000618	CcSEcCtD
Desipramine—HTR2A—GPCR downstream signaling—INSL3—testicular cancer	0.000108	0.0022	CbGpPWpGaD
Desipramine—HRH1—GPCR downstream signaling—INSL3—testicular cancer	0.000108	0.0022	CbGpPWpGaD
Desipramine—CHRM1—GPCR downstream signaling—INSL3—testicular cancer	0.000107	0.00219	CbGpPWpGaD
Desipramine—CHRM3—GPCR downstream signaling—INSL3—testicular cancer	0.000107	0.00219	CbGpPWpGaD
Desipramine—Dizziness—Doxorubicin—testicular cancer	0.000106	0.000604	CcSEcCtD
Desipramine—CHRM2—GPCR downstream signaling—INSL3—testicular cancer	0.000106	0.00216	CbGpPWpGaD
Desipramine—CYP2D6—Biological oxidations—HPGDS—testicular cancer	0.000105	0.00215	CbGpPWpGaD
Desipramine—Nausea—Epirubicin—testicular cancer	0.000103	0.000586	CcSEcCtD
Desipramine—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	0.000103	0.0021	CbGpPWpGaD
Desipramine—Vomiting—Doxorubicin—testicular cancer	0.000102	0.000581	CcSEcCtD
Desipramine—Rash—Doxorubicin—testicular cancer	0.000101	0.000576	CcSEcCtD
Desipramine—Dermatitis—Doxorubicin—testicular cancer	0.000101	0.000575	CcSEcCtD
Desipramine—Headache—Doxorubicin—testicular cancer	0.000101	0.000572	CcSEcCtD
Desipramine—DRD2—Signaling by GPCR—INSL3—testicular cancer	9.96e-05	0.00203	CbGpPWpGaD
Desipramine—CHRM1—Regulation of Actin Cytoskeleton—FGFR3—testicular cancer	9.88e-05	0.00202	CbGpPWpGaD
Desipramine—CHRM3—Regulation of Actin Cytoskeleton—FGFR3—testicular cancer	9.85e-05	0.00201	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—INSL3—testicular cancer	9.8e-05	0.002	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—INSL3—testicular cancer	9.78e-05	0.002	CbGpPWpGaD
Desipramine—CHRM2—Regulation of Actin Cytoskeleton—FGFR3—testicular cancer	9.76e-05	0.00199	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—INSL3—testicular cancer	9.75e-05	0.00199	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—INSL3—testicular cancer	9.72e-05	0.00198	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—INSL3—testicular cancer	9.62e-05	0.00197	CbGpPWpGaD
Desipramine—Nausea—Doxorubicin—testicular cancer	9.55e-05	0.000543	CcSEcCtD
Desipramine—SMPD1—Metabolism—STK11—testicular cancer	9.34e-05	0.00191	CbGpPWpGaD
Desipramine—CYP1A2—Biological oxidations—HPGDS—testicular cancer	8.9e-05	0.00182	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—INSL3—testicular cancer	8.54e-05	0.00174	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—INSL3—testicular cancer	8.18e-05	0.00167	CbGpPWpGaD
Desipramine—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	7.45e-05	0.00152	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—INSL3—testicular cancer	7e-05	0.00143	CbGpPWpGaD
Desipramine—CYP3A4—Biological oxidations—HPGDS—testicular cancer	6.87e-05	0.0014	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—INSL3—testicular cancer	6.85e-05	0.0014	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—INSL3—testicular cancer	6.7e-05	0.00137	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—INSL3—testicular cancer	6.67e-05	0.00136	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—INSL3—testicular cancer	5.88e-05	0.0012	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—INSL3—testicular cancer	5.79e-05	0.00118	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—INSL3—testicular cancer	5.78e-05	0.00118	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—INSL3—testicular cancer	5.76e-05	0.00118	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—INSL3—testicular cancer	5.74e-05	0.00117	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—INSL3—testicular cancer	5.68e-05	0.00116	CbGpPWpGaD
Desipramine—SLC22A3—Metabolism—HPGDS—testicular cancer	5.57e-05	0.00114	CbGpPWpGaD
Desipramine—CYP2C18—Metabolism—HPGDS—testicular cancer	5.26e-05	0.00107	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	4.39e-05	0.000896	CbGpPWpGaD
Desipramine—SLC22A3—Metabolism—STK11—testicular cancer	4.05e-05	0.000826	CbGpPWpGaD
Desipramine—CYP2C18—Metabolism—STK11—testicular cancer	3.82e-05	0.000781	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—HPGDS—testicular cancer	3.49e-05	0.000713	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	3.42e-05	0.000698	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—HPGDS—testicular cancer	3.25e-05	0.000665	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—HPGDS—testicular cancer	3.21e-05	0.000655	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—HPGDS—testicular cancer	3.01e-05	0.000614	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—H2AFZ—testicular cancer	2.73e-05	0.000558	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—STK11—testicular cancer	2.72e-05	0.000555	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—H2AFZ—testicular cancer	2.62e-05	0.000535	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—STK11—testicular cancer	2.6e-05	0.000532	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—HPGDS—testicular cancer	2.59e-05	0.000528	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—STK11—testicular cancer	2.54e-05	0.000518	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—HPGDS—testicular cancer	2.53e-05	0.000517	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—KITLG—testicular cancer	2.51e-05	0.000514	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—KITLG—testicular cancer	2.41e-05	0.000492	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—STK11—testicular cancer	2.36e-05	0.000483	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—STK11—testicular cancer	2.33e-05	0.000476	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—H2AFZ—testicular cancer	2.24e-05	0.000458	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—STK11—testicular cancer	2.23e-05	0.000455	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—H2AFZ—testicular cancer	2.19e-05	0.000448	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—STK11—testicular cancer	2.18e-05	0.000446	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—STK11—testicular cancer	2.18e-05	0.000445	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—H2AFZ—testicular cancer	2.14e-05	0.000438	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—H2AFZ—testicular cancer	2.13e-05	0.000436	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—STK11—testicular cancer	2.13e-05	0.000436	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—STK11—testicular cancer	2.12e-05	0.000433	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—KITLG—testicular cancer	2.06e-05	0.000421	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—KITLG—testicular cancer	2.02e-05	0.000412	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—KITLG—testicular cancer	1.97e-05	0.000403	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—KITLG—testicular cancer	1.96e-05	0.000401	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—HPGDS—testicular cancer	1.95e-05	0.000399	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—HPGDS—testicular cancer	1.91e-05	0.00039	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—H2AFZ—testicular cancer	1.88e-05	0.000385	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—STK11—testicular cancer	1.88e-05	0.000384	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—STK11—testicular cancer	1.87e-05	0.000382	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—FGFR3—testicular cancer	1.87e-05	0.000382	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—H2AFZ—testicular cancer	1.85e-05	0.000378	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—H2AFZ—testicular cancer	1.85e-05	0.000378	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—H2AFZ—testicular cancer	1.84e-05	0.000376	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—STK11—testicular cancer	1.84e-05	0.000376	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—STK11—testicular cancer	1.84e-05	0.000376	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—STK11—testicular cancer	1.84e-05	0.000375	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—H2AFZ—testicular cancer	1.84e-05	0.000375	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—STK11—testicular cancer	1.83e-05	0.000374	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—STK11—testicular cancer	1.83e-05	0.000373	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—H2AFZ—testicular cancer	1.82e-05	0.000372	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—STK11—testicular cancer	1.81e-05	0.000369	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—HPGDS—testicular cancer	1.8e-05	0.000367	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—FGFR3—testicular cancer	1.79e-05	0.000366	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—KITLG—testicular cancer	1.73e-05	0.000354	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—KIT—testicular cancer	1.72e-05	0.00035	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—KITLG—testicular cancer	1.7e-05	0.000348	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—KITLG—testicular cancer	1.7e-05	0.000347	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—KITLG—testicular cancer	1.7e-05	0.000346	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—KITLG—testicular cancer	1.69e-05	0.000345	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—KITLG—testicular cancer	1.67e-05	0.000342	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—KIT—testicular cancer	1.64e-05	0.000336	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—FGFR3—testicular cancer	1.53e-05	0.000313	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—HPGDS—testicular cancer	1.52e-05	0.000311	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—FGFR3—testicular cancer	1.5e-05	0.000306	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—FGFR3—testicular cancer	1.47e-05	0.0003	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—FGFR3—testicular cancer	1.46e-05	0.000298	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—STK11—testicular cancer	1.42e-05	0.00029	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—KIT—testicular cancer	1.41e-05	0.000288	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—STK11—testicular cancer	1.39e-05	0.000283	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—KIT—testicular cancer	1.38e-05	0.000281	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—KIT—testicular cancer	1.35e-05	0.000275	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—KIT—testicular cancer	1.34e-05	0.000274	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—STK11—testicular cancer	1.31e-05	0.000267	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—FGFR3—testicular cancer	1.29e-05	0.000263	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—FGFR3—testicular cancer	1.27e-05	0.000259	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—FGFR3—testicular cancer	1.26e-05	0.000258	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—FGFR3—testicular cancer	1.26e-05	0.000257	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—FGFR3—testicular cancer	1.26e-05	0.000257	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—FGFR3—testicular cancer	1.24e-05	0.000254	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—KIT—testicular cancer	1.18e-05	0.000241	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—HPGDS—testicular cancer	1.18e-05	0.00024	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—KIT—testicular cancer	1.16e-05	0.000238	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—KIT—testicular cancer	1.16e-05	0.000237	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—KIT—testicular cancer	1.16e-05	0.000236	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—KIT—testicular cancer	1.15e-05	0.000236	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—KIT—testicular cancer	1.14e-05	0.000233	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—STK11—testicular cancer	1.11e-05	0.000226	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—STK11—testicular cancer	8.54e-06	0.000174	CbGpPWpGaD
